Medical Oncology

, Volume 29, Issue 4, pp 2824–2830 | Cite as

PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker

  • Sayaka Yuzawa
  • Mitsunobu R. Kano
  • Takahiro Einama
  • Hiroshi Nishihara
Original Paper


Pancreatic adenocarcinoma is a lethal disease that often develops a desmoplastic reaction in tumor stroma. In general, desmoplasia is thought to promote tumor growth. However, its molecular pathology and prognostic potential have not been fully investigated. Here, we investigate 26 cases of pancreatic ductal adenocarcinoma and examine the clinicopathological association between survival and expression levels of several molecular markers for stromal cells. These include alpha-smooth muscle actin (SMA) and platelet-derived growth factor (PDGF) receptor β (PDGFRβ). Both are markers of activated fibroblasts or pancreatic stellate cells (PSCs) that play an important role in desmoplasia. The staining patterns of both molecular markers were not uniform, so we categorized them into 3 grades (high, middle, and low) according to intensity. Interestingly, Kaplan–Meier analysis revealed that higher expression of PDGFRβ matched shorter prognosis (p = 0.0287, log-rank test) as well as lymphatic invasion and lymph node metastasis, whereas SMA did not (p = 0.6122). Our results suggest the prognostic potential of cancer stroma via PDGF-B signaling. Regulation of PDGF-B-associated signaling crosstalk between cancer cells and stroma cells, therefore, may indicate a possible therapeutic target for desmoplastic malignant tumors such as pancreatic adenocarcinoma.


Pancreatic adenocarcinoma Tumor stroma Prognosis PDGFRβ SMA 


  1. 1.
    Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:2403–13.PubMedGoogle Scholar
  2. 2.
    Katz MHG, Hwang R, Fleming JB, et al. Tumor-node-metastasis staging of pancreatic adenocarcinoma. CA Cancer J Clin. 2008;58:111–25.PubMedCrossRefGoogle Scholar
  3. 3.
    Smith RA, Tang J, Tudur-Smith C, et al. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. Br J Cancer. 2011;104:1440–51.PubMedCrossRefGoogle Scholar
  4. 4.
    Singh P, Srinivasan R, Wig JD. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment. Pancreas. 2011;40:644–52.PubMedCrossRefGoogle Scholar
  5. 5.
    Mitsunaga S, Hasebe T, Iwasaki M, et al. Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas. Cancer Sci. 2005;96:858–65.PubMedCrossRefGoogle Scholar
  6. 6.
    Farrow B, Albo D, Berger DH. The role of the tumor microenvironment in the progression of pancreatic cancer. J Surg Res. 2008;149:319–28.PubMedCrossRefGoogle Scholar
  7. 7.
    Erkan M, Reiser-Erkan C, Michalski CW, et al. Tumor microenvironment and progression of pancreatic cancer. Exp Oncol. 2010;32:128–31.PubMedGoogle Scholar
  8. 8.
    Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6:392–401.PubMedCrossRefGoogle Scholar
  9. 9.
    Watsky MA, Weber KT, Sun Y, et al. New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies. Int Rev Cell Mol Biol. 2010;282:165–92.PubMedCrossRefGoogle Scholar
  10. 10.
    Tang WW, Ulich TR, Lacey DL, et al. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol. 1996;148:1169–80.PubMedGoogle Scholar
  11. 11.
    Kaur H, Chaurasia SS, de Medeiros FW, et al. Corneal stroma PDGF blockade and myofibroblast development. Exp Eye Res. 2009;88:960–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Paulsson J, Sjöblom T, Micke P, et al. Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. Am J Pathol. 2009;175:334–41.PubMedCrossRefGoogle Scholar
  13. 13.
    Betsholtz C. Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev. 2004;15:215–28.PubMedCrossRefGoogle Scholar
  14. 14.
    Ostman A, Heldin C-H. PDGF receptors as targets in tumor treatment. Adv Cancer Res. 2007;97:247–74.PubMedCrossRefGoogle Scholar
  15. 15.
    Apperley JF, Gardembas M, Melo JV, et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med. 2002;347:481–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Japan Panceas Society. Classification of pancreatic carcinoma. 3rd ed. Tokyo: Kanehara Co.; 2011.Google Scholar
  17. 17.
    Edge SB. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2009.Google Scholar
  18. 18.
    Omary MB, Lugea A, Lowe AW, et al. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest. 2007;117:50–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Erkan M, Michalski CW, Rieder S, et al. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol. 2008;6:1155–61.PubMedCrossRefGoogle Scholar
  20. 20.
    Apte MV, Haber PS, Applegate TL, et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut. 1998;43:128–33.PubMedCrossRefGoogle Scholar
  21. 21.
    Masamune A, Watanabe T, Kikuta K, et al. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin Gastroenterol Hepatol. 2009;7:S48–54.PubMedCrossRefGoogle Scholar
  22. 22.
    Apte MV, Park S, Phillips PA, et al. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas. 2004;29:179–87.PubMedCrossRefGoogle Scholar
  23. 23.
    Bachem MG, Schünemann M, Ramadani M, et al. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology. 2005;128:907–21.PubMedCrossRefGoogle Scholar
  24. 24.
    Hwang RF, Moore T, Arumugam T, et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008;68:918–26.PubMedCrossRefGoogle Scholar
  25. 25.
    Vonlaufen A, Joshi S, Qu C, et al. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res. 2008;68:2085–93.PubMedCrossRefGoogle Scholar
  26. 26.
    Hägglöf C, Hammarsten P, Josefsson A, et al. Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival. PLoS ONE. 2010;5:e10747.PubMedCrossRefGoogle Scholar
  27. 27.
    Forsberg K, Valyi-Nagy I, Heldin CH, et al. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci USA. 1993;90:393–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Shao ZM, Nguyen M, Barsky SH. Human breast carcinoma desmoplasia is PDGF initiated. Oncogene. 2000;19:4337–45.PubMedCrossRefGoogle Scholar
  29. 29.
    Zeisberg M, Strutz F, Müller GA. Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol. 2000;13:S111–20.PubMedGoogle Scholar
  30. 30.
    Bronzert DA, Pantazis P, Antoniades HN, et al. Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci USA. 1987;84:5763–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Sayaka Yuzawa
    • 1
  • Mitsunobu R. Kano
    • 2
  • Takahiro Einama
    • 3
  • Hiroshi Nishihara
    • 1
  1. 1.Department of Translational Pathology, Graduate School of MedicineHokkaido UniversityHokkaidoJapan
  2. 2.Medical Scientist Training Program, Faculty of MedicineUniversity of TokyoTokyoJapan
  3. 3.Division of Gastroenterological and General Surgery, Department of SurgeryAsahikawa Medical CollegeHokkaidoJapan

Personalised recommendations